The Src and Abl family kinases activate the Spleen Tyrosine Kinase to maximize phagocytosis andLeishmaniainfection

Author:

Ullah ImranORCID,Barrie UmaruORCID,Kernen Rebecca M.,Mamula Emily T.,Datta AraniORCID,Booshehri Laela M.ORCID,Rhodes Emma L.,Bradford James M.ORCID,Wetzel Dawn M.ORCID

Abstract

ABSTRACTLeishmaniaspp. are obligate intracellular parasites that must be internalized by phagocytic cells to evade immune responses and cause disease.Leishmaniauptake is thought to be mainly host cell-driven, not parasite-driven. Promastigote (insect-stage) parasites primarily bind complement receptors (e.g., CR3) on phagocytes and are internalized through a process analogous to complement-mediated phagocytosis. Amastigote-stage parasites (proliferative forms in humans and mice) primarily bind Fc receptors and are engulfed through a process similar to immunoglobulin-mediated phagocytosis. Our previous work indicates that host Src and Abl family kinases facilitateLeishmaniaentry into macrophages and pathogenesis in murine cutaneous leishmaniasis. Here we demonstrate that host spleen tyrosine kinase (SYK) is required for efficient uptake ofLeishmaniapromastigotes and amastigotes. A Src family kinase-Abl family kinase-SYK signaling cascade inducesLeishmaniaamastigote internalization. Finally, lesion size and parasite burden duringLeishmaniainfection is significantly decreased in mice lacking SYK in monocytes or by treatment with the SYK inhibitor entospletinib. In summary, SYK is required for maximalLeishmaniauptake by macrophages and disease in mice. Our results suggest potential for treating leishmaniasis using host cell-directed agents.SUMMARY STATEMENTActivation of Spleen Tyrosine Kinase by Src and Abl family kinases is required for maximalLeishmaniauptake by macrophages and disease in a mouse model of cutaneous leishmaniasis.

Publisher

Cold Spring Harbor Laboratory

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3